Cargando…

The impact of a regional patient-centered medical home initiative on cost of care among commercially insured population in the US

The impact of a patient-centered medical home (PCMH) in reducing total cost of care remains a subject of debate, particularly among the non-elderly adult population. This study examines a 6-year experience of a large integrated regional health care delivery system in the US implementing PCMH among i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maeng, Daniel Dukjae, Sciandra, Joann P, Tomcavage, Janet F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888859/ https://www.ncbi.nlm.nih.gov/pubmed/27307773 http://dx.doi.org/10.2147/RMHP.S102826

Ejemplares similares

Cost of Treatment in a US Commercially Insured, HIV-1–Infected Population
por: Solem, Caitlyn T., et al.
Publicado: (2014)

Alcohol-Attributable Medical Costs in Commercially Insured and Medicaid Populations
por: Ozluk, Pelin, et al.
Publicado: (2022)

Costs of pediatric liver transplantation among commercially insured and Medicaid-insured patients with cholestasis in the US
por: Miloh, Tamir, et al.
Publicado: (2023)

Monthly Cost-Sharing Limits and Out-of-pocket Costs for Commercially Insured Patients in the US
por: Shafer, Paul R., et al.
Publicado: (2022)

Costs of Severe Maternal Morbidity in U.S. Commercially Insured and Medicaid Populations: An Updated Analysis
por: Black, Christopher M., et al.
Publicado: (2021)

Ambulatory Health Care Service Use and Costs Among Commercially Insured US Adults With Congenital Heart Disease
por: Agarwal, Anushree, et al.
Publicado: (2020)

Did Arkansas’ Medicaid Patient-Centered Medical Home Program Have Spillover Effects on Commercially Insured Enrollees?
por: Hinde, Jesse M., et al.
Publicado: (2020)

Utilization and Costs of Compounded Medications for Commercially Insured Patients, 2012-2013
por: McPherson, Timothy, et al.
Publicado: (2016)

Changes in Healthcare Resource Use and Costs in Commercially Insured Insomnia Patients Initiating Suvorexant
por: Kale, Hrishikesh P., et al.
Publicado: (2021)

Medical Costs of Substance Use Disorders in the US Employer-Sponsored Insurance Population
por: Li, Mengyao, et al.
Publicado: (2023)

Use of select medications prior to duloxetine initiation among commercially-insured patients
por: Bernauer, Mark, et al.
Publicado: (2012)

Liraglutide use and evaluation of pancreatic outcomes in a US commercially insured population
por: Funch, Donnie, et al.
Publicado: (2019)

Anabolic and Antiresorptive Osteoporosis Treatment: Trends, Costs, and Sequence in a Commercially Insured Population, 2003–2021
por: Wadhwa, Harsh, et al.
Publicado: (2023)

Prevalence of Renal Impairment in a US Commercially Insured Rheumatoid Arthritis Population: A Retrospective Analysis
por: Giles, Jon T., et al.
Publicado: (2021)

Comorbidities as a driver of the excess costs of community-acquired pneumonia in U.S. commercially-insured working age adults
por: Polsky, Daniel, et al.
Publicado: (2012)

Community-Acquired Pneumonia Episode Costs by Age and Risk in Commercially Insured US Adults Aged ≥50 Years
por: Sato, Reiko, et al.
Publicado: (2013)

Evaluating Costs Associated With Genetic Counseling Among Commercially Insured US Patients With Cancer From 2013 to 2019
por: Roberson, Mya L., et al.
Publicado: (2022)

Utilization and Costs of Gender-Affirming Care in a Commercially Insured Transgender Population
por: Baker, Kellan, et al.
Publicado: (2022)

Systemic overuse of health care in a commercially insured US population, 2010–2015
por: Oakes, Allison H., et al.
Publicado: (2019)

Trends in Gabapentin Prescribing in a Commercially Insured U.S. Adult Population, 2009-2016
por: Pauly, Nathan J., et al.
Publicado: (2020)

Lifetime medical costs attributable to sickle cell disease among nonelderly individuals with commercial insurance
por: Johnson, Kate M., et al.
Publicado: (2022)

Cost Burden of Endothelial Keratoplasty in Fuchs Endothelial Dystrophy: Real-World Analysis of a Commercially Insured US Population (2014–2019)
por: Dhaliwal, Deepinder K, et al.
Publicado: (2022)

Out-of-Pocket Costs for Colonoscopy After Noninvasive Colorectal Cancer Screening Among US Adults With Commercial and Medicare Insurance
por: Fendrick, A. Mark, et al.
Publicado: (2021)

Direct and Indirect Costs of Infectious Conjunctivitis in a Commercially Insured Population in the United States
por: Pepose, Jay S, et al.
Publicado: (2020)

Health Care Costs of Anal Cancer in a Commercially Insured Population in the United States
por: Wu, Chi-Fang, et al.
Publicado: (2018)

Recent Trends in the Prevalence of Crohn’s Disease and Ulcerative Colitis in a Commercially Insured US Population
por: Kappelman, Michael D., et al.
Publicado: (2012)

Healthcare Resource Use and Costs Associated with Opioid Initiation Among Patients with Newly Diagnosed Endometriosis with Commercial Insurance in the USA
por: Estes, Stephanie J., et al.
Publicado: (2020)

A retrospective analysis to estimate the healthcare resource utilization and cost associated with treatment-resistant depression in commercially insured US patients
por: Li, Gang, et al.
Publicado: (2020)

Healthcare Costs of Clostridioides difficile Infection in Commercially Insured Younger Adults
por: Sahrmann, John M, et al.
Publicado: (2023)

Comorbidity Associations with AATD Among Commercially Insured and Medicare Beneficiaries with COPD in the US
por: Sandhaus, Robert, et al.
Publicado: (2020)

Consistency and Adequacy of Public and Commercial Health Insurance for US Children, 2016 to 2021
por: Daw, Jamie R., et al.
Publicado: (2023)

Healthcare resource utilization and costs before and after long-acting injectable antipsychotic initiation in commercially insured young adults with schizophrenia
por: Fu, Alex Z., et al.
Publicado: (2022)

Association Between Prescription Cost Sharing and Adherence to Initial Combination Antiretroviral Therapy in Commercially Insured Antiretroviral-Naïve Patients with HIV
por: Johnston, Stephen S., et al.
Publicado: (2012)

Value analysis of digital breast tomosynthesis for breast cancer screening in a commercially-insured US population
por: Bonafede, Machaon M, et al.
Publicado: (2015)

Social Risk Adjustment of Quality Measures for Diabetes and Cardiovascular Disease in a Commercially Insured US Population
por: Nguyen, Christina A., et al.
Publicado: (2019)

Changes in Health Services Use Among Commercially Insured US Populations During the COVID-19 Pandemic
por: Whaley, Christopher M., et al.
Publicado: (2020)

Medical Claim Cost Impact of Improved Diabetes Control for Medicare and Commercially Insured Patients with Type 2 Diabetes
por: Fitch, Kathryn, et al.
Publicado: (2013)

Treatment Patterns and Health Care Costs in Commercially Insured Patients with Follicular Lymphoma
por: Fowler, Nathan H., et al.
Publicado: (2020)

Healthcare Utilization and Cost Burden of Porphyria in Commercially Insured Adults in the United States
por: Elsaid, Mohamed I., et al.
Publicado: (2020)

Oral Cancer Prevalence, Mortality, and Costs in Medicaid and Commercial Insurance Claims Data
por: Tranby, Eric P., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_paig7c98t6qjp2t5tnne83gkuu